article thumbnail

After a Couple of Deep Cuts in Recent Years, This 7%-Yielding Dividend Is Getting Healthier and Could Start Heading Higher in 2025 and Beyond

The Motley Fool

A significant percentage of its properties had leases with two tenants : Steward Health Care and Prospect Medical Holdings. For example, last year, it reconstituted its investment in properties related to Prospect. The REIT also allowed Prospect to pay partial rent on its California properties for a period.

Prospects 246
article thumbnail

This Ultra-High-Yield Dividend Stock is a Tale of 2 Portfolios

The Motley Fool

not leased to Steward Health Care or Prospect Medical Holdings. portfolio, excluding hospitals leased to Steward and Prospect, is seeing increased admissions. billion) and Prospect ($1.1 It also has nearly $2 billion in other assets, such as investments in operating companies (including Prospect's managed care businesses).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Will Viking Therapeutics Get Acquired?

The Motley Fool

Investors have become excited about the company's long-term prospects, as it has a promising weight-loss drug in its portfolio. Viking's balance sheet looks strong While Viking has an exciting asset in its portfolio, the numbers still have to work for a prospective buyer. And its total liabilities were just $20 million.

article thumbnail

Why Spirit Airlines Stock Fell (Again) This Week

The Motley Fool

Spirit stock subsequently fell by more than 20% as investors get more and more pessimistic about its prospects. The company's balance sheet is ugly, with $316 million in short-term debt, $3 billion in long-term debt, and over $3 billion in operating lease liabilities.

article thumbnail

Where Will Viking Therapeutics Be in 5 Years?

The Motley Fool

With its liabilities totaling $33.6 Its strong financial position could sweeten the deal for a prospective acquirer looking to add a promising GLP-1 drug to its portfolio. Its prospects for the future will hinge on whether it can bring at least one drug to market. If it does, the stock could take off.

Prospects 243
article thumbnail

Want $300 in Exceptionally Safe Annual Dividend Income? Invest $4,975 Into the Following 3 High-Yield Stocks.

The Motley Fool

But the most exciting development for Philip Morris and its prospective and existing shareholders is the growth it's seen in its smokeless tobacco products. Even if telecom companies were to eventually face some form of financial liability, it would likely be determined in the U.S. court system, which often takes years.

Investing 242
article thumbnail

Is It Time to Buy the Dow Jones' 3 Worst-Performing Stocks This Year?

The Motley Fool

Modest growth prospects, rising interest rates that have made bonds more attractive, and macroeconomic headwinds that have dissuaded consumers from spending more on phone plans have led to increased price competition among the big three telecoms, which also includes T-Mobile. billion-$12.5